Entera Bio
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | 0 | -7 | -7 | -8 |
EBITDA | -4,563 | -3,498 | -3,009 | -3,191 |
EBIT | -3,505 | -3,016 | -3,199 | |
Net Income | -7,312 | -3,505 | -3,016 | -3,200 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -3,467 | -3,090 | -2,056 | -2,786 |
Cash | 11,309 | 4,137 | 7,108 | 8,574 |
Basic Shares | 50,451 | 47,756 | 46,191 | 47,089 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $42 | $181 | $14 | $134 |
Gross Profit | -30 | 9 | -56 | 33 |
EBITDA | -11,409 | -9,481 | -8,804 | -12,953 |
EBIT | -11,439 | -9,527 | -8,860 | -13,017 |
Net Income | -11,439 | -9,541 | -8,889 | -13,071 |
Net Change In Cash | 42 | 181 | 14 | 134 |
Free Cash Flow | -7,477 | -6,821 | -7,327 | -12,546 |
Cash | 7,108 | 8,660 | 11,019 | 12,309 |
Basic Shares | 46,191 | 37,650 | 29,007 | 28,808 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.14 |
2026-03-31 | -$0.07 |
2025-12-31 | -$0.06 |
2025-09-30 | -$0.07 |